Transfusion results of filtered and subsequently stored random platelet suspensions prepared from buffy coats. 1992

V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
Red Cross Bloodbank Foundation, Leiden, The Netherlands.

There is almost general agreement that removal of leukocytes from blood components reduces the incidence of HLA-antibody formation and refractoriness to random platelet transfusions. Recently filters have become available, which are able to reduce leukocyte contamination in platelet suspensions with acceptable platelet loss. We evaluated a cellulose acetate (CA) and a polyester (PE) filter, and stored buffy coat-derived platelet suspensions after filtration. Both filters are effective for the removal of leukocytes to levels below 5 x 10(6) per transfusate. For the CA filter, platelet recovery was 73 +/- 13% yielding 256 +/- 53 x 10(9) platelets per transfusate from 6 donors. For the PE filter, platelet recovery was 90 +/- 9% and 327 +/- 51 x 10(9) platelets per transfusate. When a loading dose of less than 5 x 10(8) leukocytes was applied, 98% of the CA-filtered suspensions and 100% of the PE-filtered suspensions contained less than 5 x 10(6) residual leucocytes. In 123 patients transfusion results of CA-filtered platelet suspensions stored for 72 h, were compared with those obtained by non-stored, non filtered, random platelet suspensions which had been leukocyte depleted by differential centrifugation. Platelet increments 1 and 20 h after transfusion showed no statistical difference between CA-filtered platelet transfusions stored for 72 h and non-stored, non-filtered platelet transfusions. In a new cohort of 117 patients, two filters and various postfiltration storage times were compared. Using both filters, the 1-hour posttransfusion increments decreased to approximately 60% after 96 h of storage compared to results of storage periods of 72 h or less.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D010983 Plateletpheresis The preparation of platelet concentrates with the return of red cells and platelet-poor plasma to the donor. Blood Plateletpheresis,Thrombocytapheresis,Thrombocytopheresis,Blood Plateletphereses,Plateletphereses,Plateletphereses, Blood,Plateletpheresis, Blood,Thrombocytaphereses,Thrombocytophereses
D001760 Bleeding Time Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function. Aspirin Tolerance Test,Bleeding Time, Template,Duke Method,Ivy Method,Template Bleeding Time,Aspirin Tolerance Tests,Bleeding Times,Bleeding Times, Template,Method, Duke,Method, Ivy,Template Bleeding Times,Test, Aspirin Tolerance,Tests, Aspirin Tolerance,Time, Bleeding,Time, Template Bleeding,Times, Bleeding,Times, Template Bleeding,Tolerance Test, Aspirin,Tolerance Tests, Aspirin
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D017713 Platelet Transfusion The transfer of blood platelets from a donor to a recipient or reinfusion to the donor. Blood Platelet Transfusion,Blood Platelet Transfusions,Platelet Transfusion, Blood,Platelet Transfusions,Platelet Transfusions, Blood,Transfusion, Blood Platelet,Transfusion, Platelet,Transfusions, Blood Platelet,Transfusions, Platelet

Related Publications

V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
September 1989, Transfusion,
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
January 1995, Vox sanguinis,
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
February 1995, Annals of hematology,
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
April 1994, Transfusion,
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
June 1990, Lancet (London, England),
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
January 1992, Transfusion,
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
January 1996, Vox sanguinis,
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
August 1996, Annals of hematology,
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
March 2000, Transfusion medicine (Oxford, England),
V M Novotny, and R van Doorn, and Y Rozier, and J D'Amaro, and M S Harvey, and A Brand
January 1993, Vox sanguinis,
Copied contents to your clipboard!